Org-25935

Org-25935

SCHEMBL7703028

COc1ccc2c(c1)CC[C@H](CN(C)CC(=O)[O-])[C@@H]2c1ccccc1.[Li+]

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC6A9

The experimentally established mechanism targets of Org-25935. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A9 known ✓ P48067 2/20 0.85
TAS2R14 Q9NYV8 2/20 0.43
MTNR1B P49286 3/20 0.43
MTNR1A P48039 2/20 0.43
PPARD Q03181 2/20 0.42
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
CA14 Q9ULX7 2/20 0.40
CA12 O43570 1/20 0.40
CA7 P43166 1/20 0.40
GRIN2B Q13224 4/20 0.38
GRIN1 Q05586 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Org-25935 SCHEMBL7704305 1.00 SLC6A9 (0.85) SLC6A9TAS2R14MTNR1BMTNR1APPARD
Lithium Ion SCHEMBL7703313 0.94 SLC6A9 (0.74) SLC6A9TAS2R14MTNR1APPARDCA1
Lithium Ion SCHEMBL7706983 0.92 SLC6A9 (0.71) SLC6A9TAS2R14MTNR1BMTNR1A
Org-25935 SCHEMBL7703430 0.92 SLC6A9 (1.00) SLC6A9TAS2R14MTNR1BMTNR1APPARD
Org-25935 SCHEMBL27034881 0.92 SLC6A9 (1.00) SLC6A9TAS2R14MTNR1BMTNR1APPARD
Org-25935 SCHEMBL1761267 0.92 SLC6A9 (1.00) SLC6A9TAS2R14MTNR1BMTNR1APPARD
Lithium Ion SCHEMBL7700187 0.91 SLC6A9 (0.70) SLC6A9MTNR1BMTNR1APPARD
Org-25935 SCHEMBL7703262 0.91 SLC6A9 (0.98) SLC6A9TAS2R14MTNR1BMTNR1APPARD
Lithium Ion SCHEMBL7698462 0.90 SLC6A9 (0.69) SLC6A9MTNR1BMTNR1APPARD
Lithium Ion SCHEMBL7704091 0.90 SLC6A9 (0.69) SLC6A9MTNR1BMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100769-B1 AMINOMETHYLCARBOXYLIC ACID DERIVATIVES AKZO NOBEL NV (NL) 2002-12-04 EP disclosed
US-6410592-B1 THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS AKZO NOBEL N.V. (NL) 2002-06-25 US disclosed